CN108338941A - 人工皮脂膜及其制造方法 - Google Patents
人工皮脂膜及其制造方法 Download PDFInfo
- Publication number
- CN108338941A CN108338941A CN201810043623.5A CN201810043623A CN108338941A CN 108338941 A CN108338941 A CN 108338941A CN 201810043623 A CN201810043623 A CN 201810043623A CN 108338941 A CN108338941 A CN 108338941A
- Authority
- CN
- China
- Prior art keywords
- artificial sebum
- vitamin
- class
- raw material
- refers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002374 sebum Anatomy 0.000 title claims abstract description 35
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- 239000012528 membrane Substances 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 claims abstract description 26
- 230000000694 effects Effects 0.000 claims abstract description 18
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 13
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000004164 Wax ester Substances 0.000 claims abstract description 8
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 8
- 235000019386 wax ester Nutrition 0.000 claims abstract description 8
- 235000012000 cholesterol Nutrition 0.000 claims abstract description 7
- -1 cholesteryl ester Chemical class 0.000 claims description 15
- 239000010495 camellia oil Substances 0.000 claims description 12
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 12
- 229930003231 vitamin Natural products 0.000 claims description 9
- 235000013343 vitamin Nutrition 0.000 claims description 9
- 239000011782 vitamin Substances 0.000 claims description 9
- 229940088594 vitamin Drugs 0.000 claims description 9
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 150000003700 vitamin C derivatives Chemical class 0.000 claims description 5
- 241000195493 Cryptophyta Species 0.000 claims description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 3
- 229930003268 Vitamin C Natural products 0.000 claims description 3
- 235000009508 confectionery Nutrition 0.000 claims description 3
- 239000004519 grease Substances 0.000 claims description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- 239000010497 wheat germ oil Substances 0.000 claims description 3
- 241001122767 Theaceae Species 0.000 claims description 2
- 238000007254 oxidation reaction Methods 0.000 abstract description 8
- 230000003647 oxidation Effects 0.000 abstract description 7
- 239000003963 antioxidant agent Substances 0.000 abstract description 5
- 230000003078 antioxidant effect Effects 0.000 abstract description 5
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 abstract description 5
- 239000013589 supplement Substances 0.000 abstract description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 abstract 2
- 229940032094 squalane Drugs 0.000 abstract 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 abstract 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001840 cholesterol esters Chemical class 0.000 abstract 1
- 235000021588 free fatty acids Nutrition 0.000 abstract 1
- 235000006708 antioxidants Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- GGLIEWRLXDLBBF-UHFFFAOYSA-N Dulcin Chemical compound CCOC1=CC=C(NC(N)=O)C=C1 GGLIEWRLXDLBBF-UHFFFAOYSA-N 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000251778 Squalus acanthias Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- NWNUTSZTAUGIGA-UHFFFAOYSA-N dulcin Natural products C12CC(C)(C)CCC2(C(=O)OC2C(C(O)C(O)C(COC3C(C(O)C(O)CO3)O)O2)O)C(O)CC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1OC1OC(CO)C(O)C(O)C1O NWNUTSZTAUGIGA-UHFFFAOYSA-N 0.000 description 1
- 239000008126 dulcin Substances 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Biophysics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明提供一种人工皮脂膜及其制造方法,人工皮脂膜包括:原料成分及相对质量比例为78.4%~2%的三酸甘油脂、1%~15%的蜡酯类、20%~35%的角鲨烷、0.1%~7%的游离脂肪酸、0.1%~6%的磷脂质、0.1%~10%的胆固醇酯、0.1%~10%的胆固醇、0.1%~10%的抗氧化物及0.1%~5%的细胞活性物。本发明主要是通过修改人工皮脂膜的原料组成比例以减少其氧化所产的负面作用,并增加角鲨烷的比例,使得处于高污染下的肌肤可以恢复到正常的平衡状态,且更添加有抗氧化物与细胞活性物成分,以延长人工皮脂膜的氧化时间与补充细胞的三磷酸腺苷。
Description
技术领域
本发明为一种人工皮脂膜及其制造方法,尤是指用于制造具高抗氧化性及高渗透性的皮脂膜及其制造方法。
背景技术
现有人工皮脂膜,则普遍存在有以下缺点:第一、所含的三酸甘油脂容易氧化,长期存放后容易造成颜色与气味上的变化,且容易分解出游离脂肪酸而导致pH下降。第二、若是置放于低温环境下,则容易冻结或是造成特定熔点较高的成分释出而导致在组成成分上出现变化。再者,由于现在污染的程度日益严重(包含PM2.5悬浮微粒、紫外线、高温等因素),造成高污染地区(如人口较多的都市)居民的皮脂层屏障能力普遍不足。
综合以上内容,目前的人造皮脂可能存在容易氧化与安定性不佳的缺点,另外面对环境逆境日益增加的状况,现行的皮脂组成将会因为与污染物作用后,造成屏障程度降低,无法有效防御肌肤,因此本发明主要开发出改良的人工皮脂膜,针对上述缺点进行改善与渗透性的补强。
发明内容
本发明主要是通过修改人工皮脂膜的原料组成比例以减少其氧化所产的负面作用,并增加角鲨烷的比例,使得处于高污染下的肌肤可以恢复到正常的平衡状态,且更添加有抗氧化物与细胞活性物成分,以延长人工皮脂膜的氧化时间与补充细胞的三磷酸腺苷。
本发明提供一种人工皮脂膜,包括:原料成分及相对比例为78.4%~2%的三酸甘油脂、1%~15%的蜡酯类、20%~35%的角鲨烷、0.1%~7%的游离脂肪酸、0.1%~6%的磷脂质、0.1%~10%的胆固醇酯、0.1%~10%的胆固醇、0.1%~10%的抗氧化物及0.1%~5%的细胞活性物,上述相对比例均指质量比。
于一实施例中,抗氧化物包含:苦茶油、维他命E类、维他命C类、小麦胚芽油或不饱和脂肪酸中的任意一种或者两种以上的组合;其中,维他命 E类是指维他命E或其衍生物;维他命C类是指维他命C或其衍生物;细胞活性物包含三磷酸腺苷或藻类萃取物中的任意一种或者两种的组合。三酸甘油脂是指三酸甘油脂或其衍生物,角鲨烷是指角鲨烷或其衍生物,胆固醇酯是指胆固醇酯或其衍生物。
于一实施例中,抗氧化物中的苦茶油,则尤是指中国台湾苦茶油。
本发明提供一种上述人工皮脂膜的制造方法,包含以下步骤:(1)分别将该三酸甘油脂、该角鲨烷及该抗氧化物,以60℃~90℃进行加热混合至完全溶解,而制成第一混合原料;(2)将该蜡酯类、该游离脂肪酸、该磷脂质、该胆固醇酯及该胆固醇,以60℃~90℃进行加热混合至完全溶解,而制成第二混合原料;(3)将该第一混合原料与该第二混合原料,进行均匀混合搅拌并降温冷却至40℃~50℃时加入该细胞活性物,再进行均匀混合搅拌并降温冷却至常温,即为人工皮脂膜。
为了对本发明的技术特征进行更进一步的了解,以下谨以一具体实施例作详细说明。
具体实施方式
实施例一,一种人工皮脂膜及其制造方法,人工皮脂膜包括:原料成分及相对比例为78.4%~2%的三酸甘油脂、1%~15%的蜡酯类、20%~35%的角鲨烷、0.1%~7%的游离脂肪酸、0.1%~6%的磷脂质、0.1%~10%的胆固醇酯、0.1%~10%的胆固醇、0.1%~10%的抗氧化物及0.1%~5%的细胞活性物,上述相对比例均指质量比。
一种制造上述人工皮脂膜的方法:分别将该三酸甘油脂、该角鲨烷及该抗氧化物,以70℃进行加热混合至完全溶解,而制成第一混合原料;将该蜡酯类、该游离脂肪酸、该磷脂质、该胆固醇酯及该胆固醇,以摄氏70℃进行加热混合至完全溶解,而制成第二混合原料;将该第一混合原料与该第二混合原料,进行均匀混合搅拌并降温冷却至40~50℃时加入该细胞活性物,再进行均匀混合搅拌并降温冷却至常温,即为人工皮脂膜。其中,加热温度亦可设定于60℃~90℃之间。
而该三酸甘油脂,则是使用三酸甘油脂,在使用上亦可以用三酸甘油脂衍生物来替代。该角鲨烷,则是使用角鲨烷,在使用上亦可以用角鲨烷衍生物来替代。该胆固醇酯,则是使用胆固醇酯,在使用上亦可以用胆固醇酯衍生物来替代。
该蜡酯类,则是使用羊毛脂;该游离脂肪酸,则是使用棕榈酸;该磷脂质,则是使用卵磷脂;该胆固醇酯,则是使用羊毛固醇混合酯;该细胞活性物,则是使用三磷酸腺苷。而该抗氧化物,亦可选用包含:苦茶油、维他命 E类、维他命C类、小麦胚芽油或不饱和脂肪酸中的任意一种或者两种以上的组合;其中,该维他命E类,则是指维他命E或其衍生物;该维他命C类,则是指维他命C或其衍生物。该细胞活性物,亦可选用包含:三磷酸腺苷或藻类萃取物中的任意一种或者两种的组合。另,该抗氧化物中的苦茶油,则是使用中国台湾苦茶油。
本发明的该人工皮脂膜与一般现有技术的差异,主要是在于具有含量较低的该三酸甘油脂以减少氧化的可能与游离脂肪酸释放的负面作用;另外,可通过提高该角鲨烷在组成中的成分比例以平衡于恶劣环境中角鲨烷的快速流失,亦有助于处在高污染环境下的肌肤来恢复到正常平衡的状态;再者,更添加有该卵磷脂来做为该磷脂质以包覆于该人工皮脂膜外围而形成 0.025μm至3.5μm的球体的微脂囊,由以使得该人工皮脂膜得以快速且深入地渗透,进而被传递进入肌肤来达到填补肌肤屏障的效果。
本发明的该人工皮脂膜亦额外添加该苦茶油(使用中国台湾特有种苦茶油)来做为高效的该抗氧化物,由以减少脂质的氧化并有效延长人工皮脂膜的保存期限;其中,在抗氧化的领域上,已有文献指出苦茶油内含丰富抗氧化成分,如茶多酚、叶绿素、甘素、维生素A、维生素E、不饱和脂肪酸等,因此具有清除自由基的功效;且临床医学研究指出苦茶油具有减少血管栓塞的机率、延缓衰老、调节血脂、血糖、通便、保肝等保健功效;在营养学界有“植物黄金”的美誉,且含有角鲨烯0.5%左右,能促进血液循环、活化身体机能细胞、消炎杀菌、修复细胞、加快伤口愈合。本发明的该人工皮脂膜更添加该三磷酸腺苷来做为该细胞活性物,由以诱使细胞自行产生三磷酸腺苷,并可促进细胞呼吸作用进而加强细胞代谢的功能,且有助于处在高污染环境下的肌肤来恢复到正常平衡的状态。
本发明的该人工皮脂膜,除了具有保湿润肤的效果外,更有高抗氧化性、高渗透性与协助处于高污染环境中的肌肤恢复正常皮脂组成的作用;其中,更搭配微脂囊的快速、深度的渗透技术,来达到同时补充细胞间脂质与建构完整皮脂膜系统的优点。
上述实施例仅为说明本发明的原理及其功效,并非限制本发明;因此,本领域的技术人员对上述实施例进行修改及变化仍不脱本发明的精神。本发明已具备产业上实用性、新颖性及创造性,并符合发明专利要件,爰依法提起申请。
专有名词中英文对照表
Claims (3)
1.一种人工皮脂膜,其特征在于,包括:原料成分及相对比例为78.4%~2%的三酸甘油脂、1%~15%的蜡酯类、20%~35%的角鲨烷、0.1%~7%的游离脂肪酸、0.1%~6%的磷脂质、0.1%~10%的胆固醇酯、0.1%~10%的胆固醇、0.1%~10%的抗氧化物及0.1%~5%的细胞活性物,上述相对比例均指质量比;
该抗氧化物,则包含:苦茶油、维他命E类、维他命C类、小麦胚芽油或不饱和脂肪酸中的任意一种或者两种以上的组合;其中,该维他命E类,则是指维他命E或其衍生物;该维他命C类,则是指维他命C或其衍生物;该细胞活性物,则包含三磷酸腺苷或藻类萃取物中的任意一种或者两种的组合;
而该三酸甘油脂,则是指三酸甘油脂或其衍生物;该角鲨烷,则是指角鲨烷或其衍生物;该胆固醇酯,则是指胆固醇酯或其衍生物。
2.如权利要求1所述的人工皮脂膜,其特征在于,该抗氧化物中的该苦茶油,则尤是指中国台湾苦茶油。
3.一种制造如权利要求1或2所述的人工皮脂膜的制造方法,其特征在于,包含以下步骤:
(1)分别将该三酸甘油脂、该角鲨烷及该抗氧化物,以60℃~90℃进行加热混合至完全溶解,而制成第一混合原料;
(2)将该蜡酯类、该游离脂肪酸、该磷脂质、该胆固醇酯及该胆固醇,以60℃~90℃进行加热混合至完全溶解,而制成第二混合原料;
(3)将该第一混合原料与该第二混合原料,进行均匀混合搅拌并降温冷却至40℃~50℃时加入该细胞活性物,再进行均匀混合搅拌并降温冷却至常温,即为人工皮脂膜。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW106103047 | 2017-01-25 | ||
TW106103047A TWI633896B (zh) | 2017-01-25 | 2017-01-25 | Artificial sebum film and manufacturing method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108338941A true CN108338941A (zh) | 2018-07-31 |
Family
ID=62106514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810043623.5A Pending CN108338941A (zh) | 2017-01-25 | 2018-01-17 | 人工皮脂膜及其制造方法 |
Country Status (4)
Country | Link |
---|---|
US (1) | US10813969B2 (zh) |
CN (1) | CN108338941A (zh) |
FR (1) | FR3062061B1 (zh) |
TW (1) | TWI633896B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113332226B (zh) * | 2021-05-26 | 2023-02-28 | 上海琦成化妆品有限公司 | 一种化妆水及其制备方法 |
CN114848547A (zh) * | 2022-04-21 | 2022-08-05 | 寒霜籽(上海)生物科技有限公司 | 一种具有蜡质透气微通道的皮脂膜组合物及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3692097A (en) * | 1996-08-02 | 1998-02-25 | Plum Kemi Produktion A/S | An oil-in-water emulsion for use on human skin for cleansing, preserving or improving the condition of the skin |
US7005557B2 (en) * | 2001-07-03 | 2006-02-28 | The Procter & Gamble Company | Film-forming compositions for protecting skin from body fluids and articles made therefrom |
US20030105445A1 (en) * | 2001-11-30 | 2003-06-05 | Kimberly-Clark Worldwide, Inc. | Breast pad assembly containing a skin benefit ingredient |
CN101889966B (zh) * | 2010-06-21 | 2011-12-07 | 金奇集团金奇日化有限公司 | 一种茶油防裂霜组合物的制备方法及制品 |
-
2017
- 2017-01-25 TW TW106103047A patent/TWI633896B/zh active
-
2018
- 2018-01-16 US US15/871,997 patent/US10813969B2/en active Active
- 2018-01-17 CN CN201810043623.5A patent/CN108338941A/zh active Pending
- 2018-01-25 FR FR1850591A patent/FR3062061B1/fr active Active
Also Published As
Publication number | Publication date |
---|---|
FR3062061A1 (fr) | 2018-07-27 |
FR3062061B1 (fr) | 2020-01-03 |
US10813969B2 (en) | 2020-10-27 |
US20180133276A1 (en) | 2018-05-17 |
TW201827088A (zh) | 2018-08-01 |
TWI633896B (zh) | 2018-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102569534B1 (ko) | 식물 공급원으로부터 칸나비노이드의 선택적 추출 방법 | |
WO2006024095A8 (en) | Microemulsion & sub-micron emulsion process & compositions | |
JP2008511550A5 (zh) | ||
BR112015002366B1 (pt) | composições de mistura graxa e de pasta de gordura | |
CN108338941A (zh) | 人工皮脂膜及其制造方法 | |
CN107205419A (zh) | 油脂 | |
UA87265C2 (ru) | Способ получения пищевых гомогенных, твердых, свободных от растворителя гранул, содержащих каротиноиды | |
CN106265479A (zh) | 一种皮肤修复组合物及其制备方法 | |
KR102582681B1 (ko) | 유화 조성물 조제용 프레믹스 및 이를 이용한 조성물 | |
JP2003020495A (ja) | 油脂組成物 | |
JPS60192547A (ja) | 可食性液状配合油 | |
CN114569499B (zh) | 一种温和高效的美白组合物及其制备方法 | |
CN108208197B (zh) | 一种油脂组合物及其制备方法 | |
CN104479937A (zh) | 一种山茶抗痤疮洗脸皂 | |
CN114588066A (zh) | 一种视黄醇脂质体组合物及其制备方法 | |
CN110623856A (zh) | 一种不含乳化剂的卵磷脂乳化体及其制备方法 | |
JPH08140624A (ja) | 栄養補助食品 | |
RU2708552C1 (ru) | Масложировой продукт для функционального питания | |
TWM546817U (zh) | 透皮吸收皮脂膜組合物乳液保養品結構 | |
JP2003284515A (ja) | 炊飯用乳化組成物 | |
JP2000300191A (ja) | 植物ステロール含有組成物 | |
US2434789A (en) | Fractionation of marine oils | |
JPS635036A (ja) | スクアレン含有組成物 | |
KR20090127389A (ko) | 천연 비누 소지를 이용한 과메기 비누의 제조 방법 | |
JP2005002013A (ja) | 化粧料組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180731 |